These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3280908)
21. [Is it still possible to reduce the incidence of nephrotoxicity of aminoglycosides?]. Beauchamp D; Labrecque G; Bergeron MG Pathol Biol (Paris); 1995 Nov; 43(9):779-87. PubMed ID: 8746100 [TBL] [Abstract][Full Text] [Related]
22. The aminoglycosides. Whelton A Clin Orthop Relat Res; 1984 Nov; (190):66-74. PubMed ID: 6386262 [TBL] [Abstract][Full Text] [Related]
23. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452 [TBL] [Abstract][Full Text] [Related]
24. [Ototoxicity of aminoglycoside antibiotics]. Reiss M; Reiss G Praxis (Bern 1994); 2003 Jan; 92(4):127-33. PubMed ID: 12632843 [TBL] [Abstract][Full Text] [Related]
25. Aminoglycoside drugs in clinical practice: an evidence-based approach. Leibovici L; Vidal L; Paul M J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778 [TBL] [Abstract][Full Text] [Related]
27. Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host. Gaya H Am J Med; 1986 Jun; 80(6B):149-55. PubMed ID: 3728525 [TBL] [Abstract][Full Text] [Related]
29. Determinants of efficacy and toxicity of aminoglycosides. Mattie H; Craig WA; Pechère JC J Antimicrob Chemother; 1989 Sep; 24(3):281-93. PubMed ID: 2681115 [TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of the aminoglycoside antibiotics for systemic use. Burkle WS Drug Intell Clin Pharm; 1981 Nov; 15(11):847-62. PubMed ID: 7028438 [No Abstract] [Full Text] [Related]
31. A smart aminoglycoside hydrogel with tunable gel degradation, on-demand drug release, and high antibacterial activity. Hu J; Quan Y; Lai Y; Zheng Z; Hu Z; Wang X; Dai T; Zhang Q; Cheng Y J Control Release; 2017 Feb; 247():145-152. PubMed ID: 28077265 [TBL] [Abstract][Full Text] [Related]
35. Perioperative pharmacology: a focus on aminoglycosides. Bruce K; Hicks RW AORN J; 2011 Apr; 93(4):464-8; quiz 469-71. PubMed ID: 21459184 [TBL] [Abstract][Full Text] [Related]
36. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients. Rolston KV; Bodey GP; Elting L Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294 [TBL] [Abstract][Full Text] [Related]
37. Prudent use of the aminoglycosides. Gregory D; Hirschmann JV Postgrad Med; 1978 Sep; 64(3):97-102, 104. PubMed ID: 704499 [TBL] [Abstract][Full Text] [Related]
38. [Progress in genetic susceptibility to aminoglycoside-induced deafness]. Tian Y; Chen Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):375-379. PubMed ID: 33794642 [No Abstract] [Full Text] [Related]
39. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine. Tzovaras V; Tsimihodimos V; Kostara C; Mitrogianni Z; Elisaf M Nephrol Dial Transplant; 2011 Oct; 26(10):3219-24. PubMed ID: 21372252 [TBL] [Abstract][Full Text] [Related]